Ginkgo and Quadriparesis - a phase IV clinical study of FDA data

Summary:

Quadriparesis is reported as a side effect among people who take Ginkgo (ginkgo), especially for people who are female, 30-39 old, also take Pantoprazole, and have Pain.

The phase IV clinical study analyzes which people have Quadriparesis when taking Ginkgo. It is created by eHealthMe based on reports of 4,091 people who have side effects when taking Ginkgo from the FDA, and is updated regularly.

What is Ginkgo?

Ginkgo has active ingredients of ginkgo. It is often used in memory loss. eHealthMe is studying from 4,473 Ginkgo users. Check the latest studies of Ginkgo.

What is Quadriparesis?

Quadriparesis (muscle weakness affecting all four limbs) is found to be associated with 189 drugs and 692 conditions by eHealthMe. Check the latest studies of Quadriparesis.

On Jul, 13, 2026

4,091 people reported to have side effects when taking Ginkgo.
Among them, 19 people (0.46%) have Quadriparesis.

Among these 19 people:

What is the gender of people who have Quadriparesis when taking Ginkgo? *

female: 89.47 %
male: 10.53 %

What is the age of people who have Quadriparesis when taking Ginkgo? *

What are other drugs people take besides Ginkgo? *

What are other side effects people have besides Quadriparesis? *

Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 17 people, 89.47%
Oedema (fluid collection in tissue): 17 people, 89.47%
Weakness: 16 people, 84.21%
Pain: 16 people, 84.21%
Fainting (loss of consciousness and postural tone): 16 people, 84.21%
Dizziness: 16 people, 84.21%
Diplopia (double vision): 16 people, 84.21%
Loss Of Consciousness: 16 people, 84.21%
Stress And Anxiety: 16 people, 84.21%
Movement - Uncoordinated: 15 people, 78.95%

What are the existing conditions these people have? *

Pain: 17 people, 89.47%
Weakness: 12 people, 63.16%
Headache (pain in head): 12 people, 63.16%
Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain): 12 people, 63.16%
Rashes (redness): 11 people, 57.89%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 11 people, 57.89%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 26.32%
Constipation: 3 people, 15.79%
Faeces Hard: 3 people, 15.79%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Ginkgo and have Quadriparesis?

- Check whether Quadriparesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ginkgo:

Ginkgo (4,473 reports)

Quadriparesis treatments and more:

Quadriparesis (2,090 reports)

Browse all side effects of Ginkgo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Quadriparesis:

Quadriparesis (189 drugs)

Browse all the conditions that are associated with Quadriparesis:

Quadriparesis (692 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ginkgo (the active ingredients of Ginkgo) and Ginkgo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.